Powel H Brown Selected Research

Powel H Brown Research Topics

Disease

73	Breast Neoplasms (Breast Cancer) 04/2024 - 04/2002
71	Neoplasms (Cancer) 04/2024 - 05/2002
15	Carcinogenesis 01/2023 - 05/2002
12	Triple Negative Breast Neoplasms 03/2024 - 06/2013
5	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2023 - 10/2007
3	Inflammation (Inflammations) 01/2023 - 02/2016
3	Neoplasm Metastasis (Metastasis) 12/2020 - 08/2011
3	Body Weight (Weight, Body) 01/2017 - 08/2008
3	Prostatic Neoplasms (Prostate Cancer) 05/2016 - 09/2014
3	Hyperplasia 01/2016 - 01/2007
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2012 - 05/2006
2	Obesity 01/2024 - 01/2017
2	Adenoma (Adenomas) 01/2023 - 08/2008
2	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 01/2023 - 01/2021
2	Disease Progression 11/2022 - 01/2017
2	Overweight 01/2018 - 01/2017
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2023
1	Hepatocellular Carcinoma (Hepatoma) 01/2023
1	Non-alcoholic Fatty Liver Disease 01/2023
1	Ovarian Neoplasms (Ovarian Cancer) 11/2022

Drug/Important Bio-Agent (IBA)

37	Estrogen ReceptorsIBA 01/2024 - 11/2002
15	Tamoxifen FDA LinkGeneric 01/2016 - 09/2006
14	Bexarotene (LGD1069)FDA Link 01/2023 - 05/2002
13	Biomarkers (Surrogate Marker)IBA 04/2024 - 08/2008
13	Phosphotransferases (Kinase)IBA 01/2020 - 10/2002
13	RetinoidsIBA 02/2016 - 05/2002
12	Estrogens (Estrogen)FDA Link 01/2018 - 10/2002
11	Aromatase InhibitorsIBA 01/2023 - 01/2003
11	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 01/2016 - 10/2002
9	Hormones (Hormone)IBA 01/2024 - 01/2007
8	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2003
7	Selective Estrogen Receptor Modulators (SERM)IBA 02/2012 - 01/2003
6	Lapatinib (GW572016)FDA Link 04/2024 - 01/2009
6	Phosphoric Monoester Hydrolases (Phosphatases)IBA 03/2024 - 01/2016
6	RNA (Ribonucleic Acid)IBA 01/2023 - 04/2015
6	Transcription Factors (Transcription Factor)IBA 06/2012 - 04/2002
5	Retinoid X Receptors (Retinoid X Receptor)IBA 04/2024 - 11/2002
5	exemestane (Aromasin)FDA Link 01/2024 - 02/2012
5	Progesterone Receptors (Progesterone Receptor)IBA 01/2023 - 01/2011
5	Poly(ADP-ribose) Polymerase InhibitorsIBA 12/2017 - 01/2011
5	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 01/2014 - 01/2003
5	Raloxifene Hydrochloride (Evista)FDA Link 01/2014 - 01/2009
4	Trastuzumab (Herceptin)FDA Link 04/2024 - 08/2011
4	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 12/2020 - 05/2009
4	Vitamin D FDA LinkGeneric 01/2019 - 01/2003
4	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2016 - 10/2002
4	Cyclin D1IBA 10/2012 - 10/2007
4	Tyrosine Kinase InhibitorsIBA 02/2009 - 12/2003
3	Estradiol (Delestrogen)FDA LinkGeneric 01/2024 - 01/2007
3	Messenger RNA (mRNA)IBA 01/2024 - 01/2020
3	human ERBB2 proteinIBA 01/2024 - 08/2008
3	EnzymesIBA 01/2023 - 01/2018
3	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2023 - 01/2011
3	LipidsIBA 01/2021 - 02/2012
3	Estrogen Receptor Modulators (Antiestrogen)IBA 10/2012 - 12/2003
3	ErbB Receptors (EGF Receptor)IBA 08/2011 - 12/2003
3	Protein Isoforms (Isoforms)IBA 12/2009 - 08/2008
3	DNA (Deoxyribonucleic Acid)IBA 10/2007 - 12/2006
2	SteroidsIBA 01/2024 - 10/2004
2	AdipokinesIBA 01/2024 - 01/2021
2	Progesterone FDA LinkGeneric 01/2024 - 01/2007
2	AntigensIBA 01/2023 - 02/2009
2	Naproxen (Naprosyn)FDA LinkGeneric 01/2023 - 01/2021
2	Sulindac (Copal)FDA LinkGeneric 01/2021 - 05/2009
2	Epidermal Growth Factor (EGF)IBA 01/2019 - 05/2006
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2016 - 08/2010
2	Indicators and Reagents (Reagents)IBA 03/2016 - 01/2016
2	Phenobarbital (Luminal)FDA Link 10/2014 - 01/2007
2	LG 100268IBA 10/2012 - 10/2007
2	LigandsIBA 01/2011 - 12/2006
2	NF-kappa B (NF-kB)IBA 08/2010 - 01/2003
2	Small Interfering RNA (siRNA)IBA 12/2009 - 01/2009
2	Gefitinib (Iressa)FDA Link 02/2009 - 12/2003
2	Celecoxib (Celebrex)FDA Link 02/2009 - 08/2008
2	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2009 - 08/2008
2	Doxycycline (Periostat)FDA LinkGeneric 06/2008 - 10/2002
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 03/2006 - 05/2002
2	4- (2- (5,6,7,8- tetrahydro- 5,5,8,8- tetramethyl- 2- naphthalenyl)- 1- propenyl)benzoic acidIBA 03/2006 - 05/2002
2	Peptides (Polypeptides)IBA 10/2004 - 10/2002
1	IRX4204IBA 04/2024
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2023
1	Sialic Acid Binding Immunoglobulin-like LectinsIBA 01/2023
1	Adenosine (Adenocard)FDA LinkGeneric 01/2023
1	Protein Subunit VaccinesIBA 01/2023
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2023
1	Toll-Like Receptor 4IBA 01/2023
1	HER2 peptide (369-377)IBA 01/2023
1	ethyl 6- (N- (2- chloro- 4- fluorophenyl)sulfamoyl)cyclohex- 1- ene- 1- carboxylateIBA 01/2023
1	Everolimus FDA Link 12/2022
1	MTOR InhibitorsIBA 12/2022
1	Denosumab FDA Link 11/2022
1	RANK LigandIBA 11/2022
1	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2021
1	Matrix Metalloproteinase 7 (Matrilysin)IBA 01/2021

Therapy/Procedure

28	Therapeutics 04/2024 - 01/2003
13	Chemoprevention 01/2023 - 01/2003
2	Radiotherapy 01/2020 - 12/2017
2	Drug Therapy (Chemotherapy) 01/2019 - 02/2012
1	Oral Administration 01/2023
1	Salpingo-oophorectomy 11/2022